Market Performance - The Hang Seng Index closed down 0.87% at 25,630.54 points, while the Hang Seng Tech Index fell 1.12% to 5,515.98 points, and the National Enterprises Index decreased by 0.86% to 8,913.68 points [1] - The overall market saw declines in tech stocks, with Alibaba down 1.18%, Tencent down 0.17%, and JD Group down 1.76%, while Bilibili and Baidu saw gains of 0.42% and 1.39% respectively [1] - The annual performance of the Hang Seng Index increased by 27.77%, marking the best performance since 2017, while the Hang Seng Tech Index rose by 23.45%, the best since 2020 [2] Sector Performance - The gold and precious metals sector showed significant gains, with Zhu Feng Gold rising over 1200% and Lingbao Gold increasing by over 570% throughout the year [2] - The semiconductor sector performed well, with Huahong Semiconductor up over 240% and SMIC up over 120% [2] - The aviation sector saw strong performance, with Southern Airlines rising over 4% [1] Company Updates - Zijin Mining (02899.HK) expects a net profit of approximately RMB 51-52 billion for 2025, a year-on-year increase of about 59%-62% due to increased production and sales prices [3] - Xingqian Development (00640.HK) reported a revenue of approximately HKD 835 million for the year ending September 30, 2025, a 13.4% year-on-year increase, with net profit rising by 21.7% to approximately HKD 122 million [3] - Shanghai Electric (02727.HK) plans to sell a 47.4% stake in Electric Guoxuan and waive the right of first refusal for an additional 3.6% stake [4] Investment Insights - Everbright Securities noted that the overall profitability of Hong Kong stocks remains strong, with relatively low valuations despite recent increases, suggesting long-term investment opportunities [13] - Founder Securities highlighted positive signals from government policies aimed at optimizing the automotive industry, indicating potential for improved market conditions and value in leading automotive companies [14] - CITIC Securities projected a 7.9% increase in private residential transactions in Hong Kong for 2026, driven by a favorable interest rate environment and increased asset allocation demand [14]

Market Overview - The Hong Kong stock market opened slightly lower on December 31, with the Hang Seng Index down 0.21% at 25,801.49 points, the Hang Seng Tech Index down 0.22% at 5,566.24 points, and the National Enterprises Index down 0.23% at 8,970.49 points [1] - Major tech stocks mostly declined, with Alibaba down 0.55%, Tencent down 0.42%, and JD.com down 1.32%. Conversely, Xiaomi rose by 0.86% [1] Company News - Zijin Mining (02899.HK) expects to achieve a net profit of approximately RMB 51-52 billion for the fiscal year 2025, representing a year-on-year increase of about 59%-62% due to increased production and sales prices [2] - Starry Development (00640.HK) reported revenue of approximately HKD 835 million for the fiscal year ending September 30, 2025, a year-on-year increase of 13.4%, and a net profit of approximately HKD 122 million, up 21.7% [2] - Shanghai Electric (02727.HK) plans to sell a 47.4% stake in Electric Guoxuan and waive its preemptive rights to an additional 3.6% stake [3] - CNOOC Services (02883.HK) has recently purchased bank wealth management products totaling HKD 3 billion [4] Clinical Trials and Drug Approvals - Fosun Pharma (02196.HK) has initiated clinical trials for its integrated diagnosis and treatment nuclear medicine project SRT-007 within China [5] - Hutchison China MediTech (00013.HK) announced that its new drug application for Savolitinib, intended for treating gastric cancer patients with MET amplification, has been accepted and prioritized for review [5] Strategic Partnerships - Linkong Biotechnology Group (00690.HK) has established a strategic partnership with Wenzhou Medical University National Engineering Research Center and the Ouhai District People's Government [6] Financing Activities - Youlian International Education Leasing (01563.HK) has entered into a financing lease agreement for energy-saving equipment [7] Stock Buybacks - Tencent Holdings (00700.HK) repurchased 1.062 million shares for HKD 636 million at prices ranging from HKD 594.5 to HKD 600.5 [8] - COSCO Shipping Holdings (01919.HK) repurchased 4.3715 million shares for HKD 61.05 million at prices between HKD 13.86 and HKD 14.06 [9] - China Feihe (06186.HK) repurchased 8.837 million shares for HKD 36.34 million at prices between HKD 4.07 and HKD 4.12 [10] - Kuaishou-W (01024.HK) repurchased approximately 464,000 shares for HKD 29.88 million at prices between HKD 63.75 and HKD 64.75 [10] - Giant Bio (02367.HK) repurchased 400,000 shares for HKD 13.44 million at prices between HKD 33.48 and HKD 33.76 [11] Institutional Insights - Everbright Securities notes that the overall profitability of Hong Kong stocks remains strong, with relatively scarce assets in internet, new consumption, and innovative pharmaceuticals. Despite recent gains, valuations are still considered low, suggesting long-term investment potential [12] - Founder Securities highlights positive signals from government policies aimed at optimizing the "two new" policies, which may enhance the competitive environment in the automotive industry [12] - CITIC Securities anticipates a 7.9% increase in Hong Kong private residential transaction volumes in 2026, driven by a favorable interest rate environment and increased asset allocation demand [12]

Core Insights - Domestic beauty brands are increasingly expanding their offline presence as online traffic growth reaches its peak, with brands like Lin Qingxuan and Mao Geping leading the charge in opening new stores [1][2][3] - The shift to offline retail is driven by the need to enhance brand image and consumer trust through personalized customer service, despite the challenges of increased costs and supply chain management [1][4][7] Group 1: Expansion Strategies - Major domestic beauty brands are focusing on high-end shopping centers and have begun to penetrate lower-tier markets, with Lin Qingxuan and Mao Geping opening stores in cities like Luoyang and Chifeng [2][3] - New entrants to the offline market, such as Gu Yu and Hua Xizi, are utilizing pop-up stores to establish their brand presence in key urban areas [3][4] Group 2: Consumer Engagement and Sales Performance - Offline stores are reported to have higher conversion and repurchase rates, with Mao Geping's offline member repurchase rate increasing from 28.7% to 30.3% year-on-year, compared to 24.1% for online [7] - Lin Qingxuan's average transaction value in offline channels reached 1,026 yuan, significantly higher than the 497 yuan in online channels, indicating a strong consumer willingness to spend in physical stores [7] Group 3: Challenges and Market Dynamics - The competitive landscape for domestic beauty brands has intensified, with many brands adopting franchise and partnership models to accelerate store expansion, as seen with Lin Qingxuan increasing its number of distributors from 15 to 93 [8][11] - The offline retail environment remains challenging, with high operational costs and the need for skilled beauty consultants, leading to increased sales expenses for brands like Mao Geping [15] - The recent resurgence of beauty collection stores, which saw a sales increase of 0.39% year-on-year, provides a low-cost avenue for domestic brands to expand their market reach [12][13]

证券时报·数据宝统计，巨子生物在港交所公告显示，12月30日以每股33.480港元至33.760港元的价格回 购40.00万股，回购金额达1344.08万港元。该股当日收盘价33.540港元，下跌2.95%，全天成交额3.85亿 港元。 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.30 | 40.00 | 33.760 | 33.480 | 1344.08 | | 2025.12.29 | 40.00 | 34.760 | 34.280 | 1381.44 | | 2025.12.23 | 40.00 | 36.480 | 35.740 | 1439.66 | | 2025.12.22 | 40.00 | 36.340 | 35.860 | 1442.97 | | 2025.12.19 | 40.00 | 35.520 | 34.540 | 1405.36 | | 2025.12.18 | 40.00 | 35.040 | 34.420 | 1388.30 | | ...

Group 1 - The company, Giant Bio (02367), announced a share buyback plan, spending HKD 13.4408 million to repurchase 400,000 shares [1] - The buyback price per share ranges from HKD 33.48 to HKD 33.76 [1]

巨子生物(02367)发布公告，该公司于2025年12月30日斥资1344.08万港元回购40万股股份，每股回购价 格为33.48-33.76港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 巨子生物控股有限公司 呈交日期： 2025年12月30日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 ...

Investment Rating - The report rates the beauty and personal care industry as "Outperform" compared to the market [1] Core Insights - The beauty industry is experiencing significant growth driven by domestic brands, with a shift towards online sales channels, particularly through platforms like Douyin [2][3] - Domestic brands are gaining market share, with 43% of consumers preferring domestic beauty brands over international ones by 2025 [2][3] - The industry is characterized by high sales expense ratios due to intense competition and the need for substantial marketing investments [2][3] Summary by Sections 1. Beauty Industry Overview - The beauty sector is primarily focused on skincare and makeup, with online sales accounting for over 70% of revenue [2] - Facial care is the core category within skincare, with domestic brands experiencing growth despite overall market challenges [2][3] - The current channel structure is dominated by online sales, which account for 79% of revenue, with platforms like Taobao and Douyin leading the way [2][3] 2. Market Growth and Domestic Brand Rise - The Chinese cosmetics market is expanding, with domestic brands driving this growth [2][3] - The market size is projected to grow from 934.6 billion yuan in 2024 to 1,200 billion yuan by 2029, with a CAGR of 6.6% [2][3] - Domestic brands are expected to surpass international brands in market share by 2025, with a projected share of 52.9% by 2029 [2][3] 3. Business Model Differentiation - The domestic beauty industry has developed three main business models: efficacy research, brand deepening, and a combination of agency operations with self-owned brands [2][3] - Companies are transitioning from reliance on agency models to creating their own brands to enhance profitability [2][3] 4. Industry Characteristics and Competition - High gross margins and sales expense ratios are common in the beauty industry, driven by the need for extensive marketing to build brand recognition [2][3] - Companies are employing multi-faceted marketing strategies to balance costs and growth [2][3] 5. Investment Recommendations - The report suggests focusing on companies that excel in efficacy research, brand deepening, and transitioning from agency operations to self-owned brands [2][3] - Specific companies to watch include Juzhibio in efficacy research and Proya and Maogeping in brand deepening [2][3]

Group 1 - The stock of Giant Bio (02367.HK) experienced a decline of over 3% in the afternoon trading session, with a current drop of 2.95% to HKD 33.54 [1] - The trading volume reached HKD 246 million [1]

Core Viewpoint - The stock of Giant Bio (02367) has experienced a decline of over 3%, with a current price of HKD 33.54, and a trading volume of HKD 246 million. The downgrade of the stock rating from "Buy" to "Neutral" by China Merchants Securities International reflects the company's ongoing challenges, including reputation issues and a significant drop in sales during the Double Eleven shopping festival [1] Group 1 - China Merchants Securities International has reduced the target price for Giant Bio from HKD 64 to HKD 35, a decrease of 45% [1] - The report highlights that the core brand, Kefu Mei, has seen a double-digit decline in sales during the recent promotional period, indicating potential market difficulties [1] - The firm believes that the current market consensus may be overly optimistic regarding the company's future performance [1] Group 2 - The investment logic for Giant Bio has shifted from growth to strategic adjustment, with a cautious outlook for the company until clearer signs of stabilization emerge [1] - Revenue forecasts for 2025-2027 have been reduced by an average of 30% to align with the management's latest guidance and a more conservative view for 2026 [1] - The sales expense ratio forecast has been increased from 36% to 38% to account for execution challenges during the adjustment phase [1]